Jazz Pharmaceuticals plc (JAZZ) › Total AssetsJazz Pharmaceuticals plc (JAZZ) — Total AssetsAnnual figures by period end, from SEC filings.2010-12-31: $135.73M2011-12-31: $253.57M2012-12-31: $1.97B2013-12-31: $2.24B2014-12-31: $3.34B2015-12-31: $3.33B2016-12-31: $4.80B2017-12-31: $5.12B2018-12-31: $5.20B2019-12-31: $5.54B2020-12-31: $6.54B2021-12-31: $12.30B2022-12-31: $10.84B2023-12-31: $11.39B2024-12-31: $12.01B2025-12-31: $11.66B$11.66B2010-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$11.66B-2.9%2026-02-24Balance as of period end2024-12-31$12.01B+5.4%2026-02-24Balance as of period end2023-12-31$11.39B+5.2%2025-02-26Balance as of period end2022-12-31$10.84B-11.9%2024-02-28Balance as of period end2021-12-31$12.30B+88.2%2023-03-01Balance as of period end2020-12-31$6.54B+18.0%2022-03-01Balance as of period end2019-12-31$5.54B+6.4%2021-02-23Balance as of period end2018-12-31$5.20B+1.6%2020-02-25Balance as of period end2017-12-31$5.12B+6.7%2019-02-26Balance as of period end2016-12-31$4.80B+44.0%2018-02-27Balance as of period end2015-12-31$3.33B-0.2%2017-02-28Balance as of period end2014-12-31$3.34B+49.2%2016-02-23Balance as of period end2013-12-31$2.24B+13.8%2015-02-24Balance as of period end2012-12-31$1.97B+675.5%2014-02-25Balance as of period end2011-12-31$253.57M+86.8%2013-02-26Balance as of period end2010-12-31$135.73M—2012-02-28Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)